Sectors
SPRB
Spruce Biosciences, Inc.
58.97
2 x 44.64
2 x 77.56
bid
ask
-
1.81
2.98%
2 @ 04:10 PM
58.97 +0.00 (0.00%)
| Ytd | -32.30% | |
| 1y | 742.43% |
57.74
day range
60.90
7.20
52 week range
240.00
| Open | 60.54 | Prev Close | 60.78 | Low | 57.74 | High | 60.90 | Mkt Cap | 169.48M |
| Vol | 44.92K | Avg Vol | 67.51K | EPS | -38.43 | P/E | N/A | Forward P/E | -0.41 |
| Beta | 3.23 | Short Ratio | 0.10 | Inst. Own | 46.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 49.83 | 200-d Avg | 64.90 | 1yr Est | 1.83 |
| Income Statement | |||
| Operating Expenses | 16.51M | ||
| Research and Development Expense | 12.16M | ||
| Selling, General and Administrative Expense | 4.35M | ||
| Operating Income | -16.51M | ||
| Interest Expense | 1.10M | ||
| Net Income | -16.23M | ||
| Net Income Common Stock | -16.23M | ||
| Net Income Common Stock (USD) | -16.23M | ||
| Consolidated Income | -16.23M | ||
| Earnings per Basic Share | -6.68 | ||
| Earnings per Basic Share (USD) | -6.68 | ||
| Earnings per Diluted Share | -6.68 | ||
| Earning Before Interest & Taxes (EBIT) | -15.13M | ||
| Earning Before Interest & Taxes (USD) | -15.13M | ||
| Weighted Average Shares | 2.43M | ||
| Weighted Average Shares Diluted | 2.43M | ||
| Balance Sheet | |||
| Cash and Equivalents | 96.30M | ||
| Cash and Equivalents (USD) | 96.30M | ||
| Current Assets | 101.15M | ||
| Property, Plant & Equipment Net | 523.00K | ||
| Total Assets | 102.85M | ||
| Debt Current | 2.50M | ||
| Total Debt | 7.34M | ||
| Current Liabilities | 10.96M | ||
| Debt Non-Current | 4.84M | ||
| Total Liabilities | 19.12M | ||
| Accumulated Retained Earnings (Deficit) | -317.73M | ||
| Shareholders Equity | 83.73M | ||
| Shareholders Equity (USD) | 83.73M | ||
| Assets Non-Current | 1.70M | ||
| Total Debt (USD) | 7.34M | ||
| Liabilities Non-Current | 8.16M | ||
| Trade and Non-Trade Payables | 1.21M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 703.00K | ||
| Net Cash Flow from Financing | 64.47M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 42.22M | ||
| Capital Expenditure | -135.00K | ||
| Issuance (Purchase) of Equity Shares | 69.00M | ||
| Net Cash Flow from Investing | -135.00K | ||
| Net Cash Flow from Operations | -22.12M | ||
| Share Based Compensation | 871.00K | ||